A history of heart failure predicts arrhythmia treatment efficacy: Data from the Antiarrythmics versus Implantable Defibrillators (AVID) Study

American Heart Journal

Volumn 152, Issue 4, 2006, Pages 724-730

  Brodsky, Michael A ^a   McAnulty, John ^b   Zipes, Douglas P ^c   Baessler, Christina ^d   Hallstrom, Alfred P ^e  

^a KAISER PERMANENTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; SURVIVAL; SYNCOPE; TREATMENT OUTCOME;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; MULTICENTER STUDIES; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 33748678713     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.04.021     Document Type: Article

References (31)

1. Kjekshus J. Arrhythmias and mortality in congestive heart failure. Am J Cardiol 65 (1990) 42I-48I
2. Kannel W.B., Plehn J.F., and Cupples L.A. Cardiac failure and sudden death in the Framingham Study. Am Heart J 115 (1988) 869-875
3. Rocco M.B., Sherman H., Cook E.F., et al. Correlates of cardiac and sudden death after ambulatory monitoring in a community hospital. Importance of clinical characteristics, congestive heart failure and tachyarrhythmias. J Chronic Dis 40 (1987) 977-984
4. Holmes Jr. D.R., Davis K.B., Mock M.B., et al. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. Circulation 73 (1986) 1254-1263
5. Anderson R.D., Ohman E.M., Holmes Jr. D.R., et al. Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 32 (1998) 936-941
6. Gradman A., Deedwania P., Cody R., et al. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol 14 (1989) 564-570 [discussion 571-2]
7. Sweeney M.O., Ruskin J.N., Garan H., et al. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation 92 (1995) 3273-3281
8. Teerlink J.R., Jalaluddin M., Anderson S., et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) investigators. Circulation 101 (2000) 40-46
9. Mannino M.M., Mehta D., Langan N.M., et al. Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction. Am Heart J 131 (1996) 1251-1259
10. Sheldon R., Connolly S., Krahn A., et al. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation 101 (2000) 1660-1664
11. Bocker D., Bansch D., Heinecke A., et al. Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure. Circulation 98 (1998) 1636-1643
12. Kupari M., Lindroos M., Iivanainen A.M., et al. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. J Intern Med 241 (1997) 387-394
13. Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 98 (1998) 2282-2289
14. Pernenkil R., Vinson J.M., Shah A.S., et al. Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 79 (1997) 216-219
15. Vasan R.S., Larson M.G., Benjamin E.J., et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 (1999) 1948-1955
16. Curtis J.P., Sokol S.I., Wang Y., et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol 42 (2003) 736-742
17. Smith G.L., Masoudi F.A., Vaccarino V., et al. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 41 (2003) 1510-1518
18. Woosley R.L., Echt D.S., and Roden D.M. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents. Am J Cardiol 57 (1986) 25B-33B
19. Meissner M.D., Kay H.R., Horowitz L.N., et al. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease. Am J Cardiol 61 (1988) 1050-1055
20. Zile M.R. Heart failure with preserved ejection fraction: is this diastolic heart failure?. J Am Coll Cardiol 41 (2003) 1519-1522
21. Klapholz M., Maurer M., Lowe A.M., et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol 43 (2004) 1432-1438
22. Exner D.V., Reiffel J.A., Epstein A.E., et al. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol 34 (1999) 325-333
23. Exner D.V., Sheldon R.S., Pinski S.L., et al. Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy? Evaluation of the Canadian implantable defibrillator study implantable cardioverter defibrillatory efficacy score in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 141 (2001) 99-104
24. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. Antiarrhythmics Versus Implantable Defibrillators (AVID)-rationale, design, and methods. Am J Cardiol 75 (1995) 470-475
25. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
26. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol 34 (1999) 1552-1559
27. Domanski M.J., Sakseena S., Epstein A.E., et al. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol 34 (1999) 1090-1095
28. Luu M., Stevenson W.G., Stevenson L.W., et al. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 80 (1989) 1675-1680
29. Faggiano P, d'Aloia A, Gualeni A, et al. Mechanisms and immediate outcome of inhospital cardiac arrest in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2001;87:655-7, A10-1.
30. Teo K.K., Yusuf S., and Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 270 (1993) 1589-1595
31. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237